Life Science Trends 2017 Event in Cork on November 15th
Experts from Acorn Regulatory will be among the guest speakers at the Life Sciences Trends 2017 Conference in Little Island in Cork on November 15th next.
The conference will look at a range of topics including:
- Brexit: The Potential Impact of Brexit on Lifesciences Supply Chains
- Talent: Attracting and Maintaining Talent in Lifesciences
- Outsourcing: New Trends in Pharma & Med Tech Strategic Outsourcing
- Industry Case Studies: Bio-pharma & Medical Devices
- FDI – Attracting new investment into Munster
On the day, delegates will hear from a range of speakers and there will be the opportunity for delegates to take part in a question and answers session with the invited speakers.
The event will begin at 9am at the Radisson Blu Hotel & Spa in Little Island, Cork and will conclude at 12 noon. Registration and morning networking for the event will begin at 8.30am.
The event is free to attend and you can do book your space at the Life Sciences Trends 2017 event by clicking here. If you would like any additional information about the event then please get in touch with Acorn Regulatory by emailing email@example.com
Further Reading from Acorn Regulatory
Clinical studies are intended to advance animal health care by identifying the most effective therapies and practices for a given condition, or by advancing our basic understanding of the disease. Much like a clinical study in the human population, a veterinary clinical study involves research that gains information from animal patients.
We have been tracking the role of social media in pharmacovigilance in social media since 2015. We first wrote about it here. 5 years on, we are glad to say that the field has moved on substantially in terms of research into the practical applications of social media in Pharmacovigilance. Regulatory guidance for the industry, however, has yet to be updated.
Acorn Regulatory is a leading regulatory, pharmacovigilance, and clinical consultancy company headquartered in Ireland. Our Clinical & Medical team works with the largest and the leading companies in life sciences to assist them in bringing their products to market. The team, led by Dr. Danica Cvetkovic, has written extensively on the issue. In the latest e-book from Acorn Regulatory, we look at the best and most popular articles from our Clinical & Medical team.
Writing a risk management plan (RMP) for the first time can be a daunting task. The RMP is a legally binding regulatory document submitted to health authorities and is a mandatory commitment for all Marketing Authorisation Holders in the European Union. The goal of the RMP is to improve the benefit-risk balance of a medicinal product by combining risk assessment and risk minimisation. The RMP is a complex document, but with the revised RMP module (March 2017), comes the revised EU template for RMPs (rev 2 format) and the RMP is now structured in a clear manner with less repetition and with attention to detail.